IACFS/ME conference to include Koroshetz and Fluge

This year’s conference of the International Association for CFS/ME (IACFS/ME) in Fort Lauderdale, Florida on 27–30 October will include speeches by Dr. Walter Koroshetz and Dr. Øystein Fluge.
Dr Koroshetz, who is Director of the National Institute of Neurological Disorders and Stroke and head of the Trans-NIH ME/CFS Working Group, will give the conference’s keynote address. He is involved in creating the National Institutes of Health’s planned intramural, biomedical study on ME/CFS.
Dr Fluge, with his colleague Dr Olav Mella, is based at Haukeland University Hospital at the University of Bergen, Norway. They are responsible for the groundbreaking randomised, placebo-controlled trial of the immune-therapy drug rituximab for ME/CFS, which was published in 2011, and the current large follow-up multi-centre study. They are also conducting several substudies on ME/CFS patients, looking at possible problems in the endothelium (the cells that line blood vessels); gastrointestinal functioning; and the genetics of families who have close relatives with the disease.
IACFS/ME has held its research and clinical conferences approximately every two years since 1996. The theme of the 2016 conference is “emerging science and clinical care” and it includes lectures tailored for patients and their supporters.
The Institute for Neuro Immune Medicine at Nova Southeastern University, based in Fort Lauderdale, will host a pre-conference day of talks on October 26.
Registration information and a programme will be available nearer to the conference date.

Facebook
Twitter
WhatsApp
Email

Latest News

Text across top of image reads: "Experts in infection associated chronic illness" with "WE WANT YOU!" bolded below it. Hand with finger pointed out at viewer. "Apply now" buttons to the left and right with mouse cursor clicking on them.

Infection-associated chronic disease experts needed at ARPA-H

Congress launched ARPA-H (the Advanced Research Projects Agency for Health) this past March to focus on high-risk, high-reward research projects with the goal to solve intractable health problems. As ARPA-H is in the process of hiring its first cohort of program managers, #MEAction and a coalition of chronic disease advocacy groups have published an open

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top